ClinicalTrials.govpublic full text
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
adynamic bone disease, chronic kidney diseases, cardiac disease, chronic kidney disease-mineral and bone disorder, fracture risk, teriparatide, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827949
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.